Skip to main content

Home/ Cancer/ Group items tagged probiotics

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

The application of probiotics in cancer - Br J Nutr. 2007 Oct (full text) - 0 views

journals.cambridge.org/...displayFulltext

2007 Ocober bjn study review colon cancer colon_cancer breast breast_cancer probiotics intestine immune function immunity lactic_acid_bacteria nutrition medline Lactobacillus_helveticus R389 L89 yoghurt yogurt

shared by Matti Narkia on 13 Apr 09 - No Cached
  • Matti Narkia on 13 Apr 09
     
    The application of probiotics in cancer. de Moreno de LeBlanc A, Matar C, Perdigón G. Br J Nutr. 2007 Oct;98 Suppl 1:S105-10. Review. PMID: 17922945 doi:10.1017/S0007114507839602
Matti Narkia

Toward a Core Nutraceutical Program for Cancer Management -- McCarty and Block 5 (2): 1... - 0 views

ict.sagepub.com/...150

Nutraceutical Program Cancer Management diet dietary nutrition nutraceuticals nutritional supplements treatment therapy omega-3 green tea egcg selenium silymarin tetrathiomolybdate probiotics modified citrus pectin mcp imported vitamin_D fish_oil

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    M. F. McCarty and K. I. Block Toward a core nutraceutical program for cancer management. Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171.
Matti Narkia

Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disea... - 0 views

www.thorne.com/...223.pdf

2003 August study review Th1_Th2 balance Th:Th2 Th1 Th2 immune function immunity hypothesis limitations implications health medline altmed cam nutrition plant sterols phytosterols melatonin probiotics progesterone selenium zinc thorne cancer

shared by Matti Narkia on 14 Apr 09 - Cached
  • Matti Narkia on 14 Apr 09
     
    Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Kidd P. Altern Med Rev. 2003 Aug;8(3):223-46. Review. PMID: 12946237 Th1 pathways typically produce activation of cytotoxic T lymphocytes (Tc), NK cells, macrophages, and monocytes, all of which can attack cancer cells and generally defend against tumors.55 IFN-gamma and other Th1 cytokines are typically lower in advanced cancer patients, while the Th2 marker IL-4 can be higher or unchanged
1 - 3 of 3
Showing 20▼ items per page